Find information on thousands of medical conditions and prescription drugs.

Levophed

Norepinephrine (INN) or noradrenaline (BAN) is a catecholamine and a phenethylamine with chemical formula C8H11NO3. It is released from the adrenal glands as a hormone into the blood, but it is also a neurotransmitter in the nervous system where it is released from noradrenergic neurons during synaptic transmission. As a stress hormone, it affects parts of the human brain where attention and impulsivity are controlled. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Along with epinephrine, this compound effects the fight-or-flight response, activating the sympathetic nervous system to directly increase heart rate, release energy from fat, and increase muscle readiness.

The host of physiological changes activated by a stressful event are unleashed in part by activation of a nucleus in the brain stem called the locus ceruleus. This nucleus is the origin of most norepinephrine pathways in the brain. Neurons using norepinephrine as their neurotransmitter project bilaterally from the locus ceruleus along distinct pathways to the cerebral cortex, limbic system, and the spinal cord, among other projections.

At synapses it acts on both alpha and beta adrenoreceptors.

Antidepressants

Changes in the norepinephrine system are implicated in depression. Serotonin-norepinephrine reuptake inhibitors (SNRIs) treat depression by increasing the amount of serotonin and norepinephrine available to postsynaptic cells in the brain. There is some recent evidence showing that the norepinephrine transporter also normally transports some dopamine as well, implying that SNRIs may also increase dopamine transmission. This is because SNRIs work by preventing the serotonin and norepinephrine transporter from taking their respective neurotransmitters back to their storage vesicles for later use. If the norepinephrine transporter normally recycles some dopamine too, then SNRIs will also enhance dopaminergic transmission. Therefore, the antidepressant effects associated with increasing norepinephrine levels may also be partly or largely due to the concurrent increase in dopamine (particularly in the prefrontal cortex).

Some other antidepressants (for example some tricyclic antidepressants (TCAs)) affect norepinephrine as well, in some cases without affecting other neurotransmitters (at least not directly).

Role in attention

Norepinephrine, along with dopamine, has come to be recognized as playing a large role in attention and focus. In response, Eli Lilly Pharmaceuticals has released Strattera (atomoxetine), a selective norephinephrine reuptake inhibitor, for the treatment of ADHD in adults and children. Strattera is unique in medications specifically indicated for ADHD, as, unlike the psychostimulants (methylphenidate, dextroamphetamine, Adderall (a racemic mixture of amphetamine salts)), it affects norephinephrine, rather than dopamine. As a result, Strattera has a very low abuse potential and can act 24 hours-per-day. (It should be noted that some antidepressants, including SNRIs, have been used off-label for treatment of ADHD.)

Clinical use

Norepinephrine (commonly referred to by the brand name Levophed) is also a powerful medicine used in critically-ill patients as a vasopressor. It is given intravenously and acts on both alpha-1 and beta-1 adrenergic receptors to cause vasoconstriction. Norepinephrine is mainly used to treat patients in septic shock.

Read more at Wikipedia.org


[List your site here Free!]


Validity of scoring systems to predict risk of prolonged mechanical ventilation after coronary artery bypass graft surgery
From CHEST, 7/1/02 by Sachin Yende

Study objective: Two scoring systems, (the Spivack scoring system [SSS] and the cardiac risk score [CRS]), have been proposed to predict the risk of prolonged mechanical ventilation (PMV) after coronary artery bypass graft surgery (CABG). The primary objective of this study was to validate the efficacy of these scoring systems to predict the risk of PMV.

Design: Prospective observational study.

Setting: Cardiovascular surgical ICU.

Patients: Three hundred forty-eight patients underwent CABG. Following surgery, patients were extubated by a standardized respiratory weaning protocol.

Measurements and results: Forty-nine percent of patients had SSS > 0 and had significantly longer duration of mechanical ventilation. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the SSS for failure to extubate at 48 h are 80, 49, 9%, and 98%, respectively. Two hundred thirty-two patients (67.5%), 101 patients (29%), and 12 patients (3.5%) had a CRS of 0 to 4, 5 to 8, and > 8, respectively. Patients with lower scores had shorter duration of mechanical ventilation. The sensitivity, specificity, PPV, and NPV of the CRS for failure to extubate at 10 h are 42, 73, 47% and 69%, respectively.

Conclusion: The SSS may be used as a preoperative screening tool. A simple questionnaire that includes history of unstable angina, diabetes, congestive heart failure, and smoking prior to hospital admission can be used to calculate the SSS. Patients with SSS [less than or equal to] 0 are at low risk for PMV and can proceed to surgery without further evaluation.

Key words: coronary artery bypass grafting; failure to wean; prolonged mechanical ventilation; scoring system

Abbreviations: CABG = coronary artery bypass graft surgery; CHF = congestive heart failure; CI = confidence interval; COMFAC = comorbid risk factor score; CRS = cardiac risk score; EF = ejection fraction; NPV = negative predictive value; NS = not significant; OPCAB = off-pump coronary artery bypass surgery; PFT = pulmonary function test; PMV = prolonged mechanical ventilation; PPV = positive predictive value; ROC = receiver operating curve; SSS = Spivack scoring system

**********

Coronary artery bypass graft surgery (CABG) is the most common cardiac surgery in the United States. (1) Prolonged mechanical ventilation (PMV) is a common complication after CABG. Although the exact definition of PMV is controversial, the incidence of PMV (> 24 h) after first and reoperation CABG is 5.6% and 10.7%, respectively. (2) PMV increases duration of ICU as well as hospital stay, and resource utilization. Therefore, risk stratification for PMV is an important part of the preoperative evaluation. Although spirometry and arterial blood gas analysis are often performed as part of the preoperative evaluation, insufficient evidence exists to recommend routine use of these tests. (3,4)

Two scoring systems based on clinical criteria alone have been specifically proposed to predict PMV after CABG. Spivack et al (5) proposed a scoring system based on preoperative risk factors (the Spivack scoring system [SSS]). Since the SSS is based on preoperative clinical criteria alone, it can be used to predict risk of PMV prior to CABG. Wong et al (6) proposed a cardiac risk score (CBS) based on preoperative as well as postoperative risk factors.

We attempted to validate both of these scoring systems in a prospective observational study. Since the complex formula complicates the routine use of the SSS, we also propose a simplified approach to identify low-risk patients using the SSS.

MATERIALS AND METHODS

Study Design

A prospective observational cohort study was conducted at Methodist Healthcare University Hospital, Memphis, TN, between June 1999 and July 2000 to study outcomes of CABG. The Institutional Review Board of Methodist Healthcare of Memphis approved the protocol. A post hoc analysis was performed to validate both scoring systems.

Patient Population

Patients were identified prior to surgery. All patients undergoing conventional CABG or off-pump CABG (OPCAB) were included. Patients undergoing combined valve surgery and CABG were excluded.

Data Collection

Preoperative patient characteristics, significant intraoperative risk factors, and both perioperative and postoperative complications were recorded on all patients. The definitions from the Society of Thoracic Surgeons cardiac surgery database were used. (2) Patients were followed until discharge to home or a rehabilitation facility. Patients were contacted via telephone 30 days after discharge to determine complications following discharge.

Protocol

A standardized respiratory weaning protocol was followed after surgery to discontinue patients from mechanical ventilation. After arrival in the ICU, fraction of inspired oxygen was decreased from 1.0 to 0.4 while maintaining oxygen saturation > 93%. Once the fraction of inspired oxygen goal was reached, level of consciousness, FVC, and negative inspiratory force were then assessed in all patients. Patients who were alert and had an FVC > 1 L and negative inspiratory force > 20 cm [H.sub.2]O were switched from assist/control mode to the continuous positive airway pressure mode without pressure support. Patients were extubated if a blood gas analysis after 30 min showed pH > 7.3, PC[O.sub.2] < 50 mm Hg, and P[O.sub.2] > 70 mm Hg. If patients did not respond to the protocol, the surgeon or critical care physician were contacted and subsequent weaning attempts were continued based on specific physician orders. The total duration of mechanical ventilation in hours (in increments of 15 min) was calculated.

Inotropes were used at the discretion of ICU nurses and physicians, generally to maintain a mean arterial BP of approximately 100 mm Hg, and a cardiac index > 2 L/min/[m.sup.2]. The doses of inotropes were adjusted frequently, and multiple inotropes were often used concomitantly. Therefore, for purposes of analysis, all inotropes were combined, including dopamine, dobutamine, amrinone, milrinone, levophed, and epinephrine. The total duration of all inotropes initiated during surgery and within first 48 h was calculated.

Scoring Systems

SSS: Comorbid risk factors included history of smoking, diabetes, unstable angina, and congestive heart failure (CHF) prior to hospital admission. Each risk factor was assigned 0.25 points, and the total comorbid risk factor score (COMFAC) was calculated as follows: SSS = 5.409 (COMFAC) - 0.437 (ejection fraction [EF]) - 1.821. Patients with SSS > 0 were considered to be high risk, whereas those with SSS [less than or equal to] 0 were at low risk for PMV.

CRS: Points were assigned as follows: preoperative, age > 75 years (3 points), age 61 to 75 years (2 points), and female gender (2 points); postoperative, excessive bleeding (6 points), intraaortic balloon pump (6 points), inotrope use (2 points), and atrial arrhythmia (2 points). Excessive postoperative bleeding was defined as bleeding > 100 mL/h from the chest tube or need for re-exploration secondary to bleeding. Inotrope use was defined as use of any inotrope (defined previously) during the first 48 h following surgery. The CRS was calculated in all patients. Patients were further classified into three groups based on the CRS (0 to 4, 5 to 8, and > 8, respectively).

End Points

Different cutoffs of duration of mechanical ventilation were used to define PMV in the two studies. (5,6) Spivack et al (5) defined PMV as need for mechanical ventilation > 48 h for the SSS. The CRS by Wong et al (6) defined PMV as need for mechanical ventilation > 10 h.

Statistical Analysis

All statistical tests were performed as two-tailed tests. Fisher exact test or [chi square] were used to compare difference in proportions. Continuous variables were expressed as mean ([+ or -] SD or SEM) and compared with parametric (Student t test) or nonparametric (Wilcoxon) test based on distribution of variables. Kaplan-Meier curves were constructed, and a log-rank test was used to determine association of scoring system and duration of mechanical ventilation, length of ICU, and hospital stay. A p value < 0.05 was considered statistically significant.

A simple linear regression model was used to determine the relation between duration of mechanical ventilation and individual scoring system. For this analysis, the duration of mechanical ventilation (in hours) was considered as the dependent variable. The duration of mechanical ventilation was logarithmically transformed since its distribution was not normal. The point estimate ([beta]) and Pearson product correlation coefficient ([rho] or r) were calculated for each scoring system. Statistical analysis was performed using software (JMP version 3.2.2; SAS Institute; Cary, NC).

RESULTS

Three hundred forty-eight patients were enrolled in this prospective observational study. Three patients were excluded due to death within 48 h. Extubation at 10 h and 48 h was unsuccessful in 125 patients (36.3%) and 18 patients (5.2%), respectively.

One hundred sixty-eight of 345 patients (49%) had SSS > 0. Preoperative and intraoperative characteristics of patients with SSS [less than or equal to] 0 and SSS > 0 are summarized in Table 1. EF, history of smoking, diabetes, CHF, and unstable angina, which are part of the SSS, were significantly different in these two subgroups. In addition, the patients with SSS > 0 had higher incidence chronic lung disease. Patients with SSS > 0 were associated with longer duration of mechanical ventilation (Fig 1, Table 2). The patients with a lower score were more likely to be successfully extubated at 48 h (Table 2). On multivariable analysis, this association was independent of age, gender, chronic lung disease, type of surgery (conventional vs OPCAB), and duration on bypass machine. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of SSS at 48 h are summarized in Table 3.

[FIGURE 1 OMITTED]

The role of SSS was further analyzed in subgroups of patients undergoing elective (n = 63), urgent (n = 261), and emergent or salvage (n = 24) surgery. Patients with SSS [less than or equal to] 0 were associated with shorter duration of mechanical ventilation in the elective subgroup (8.6 h vs 30.6 h, p = 0.003) and urgent subgroup (10.6 h vs 32 h, p = 0.047). However, SSS was not associated with duration of mechanical ventilation in the emergent subgroup (33.6 h vs 28.6 h, p = not significant [NS]).

CRS of 0 to 4, 5 to 8, and > 8 occurred in 232 patients (67%), 101 patients (29%), and 12 patients (3.5%), respectively. Preoperative and intraoperative characteristics of the three groups are summarized in Table 4. The only factors not specifically included in the CRS (age, gender) were lower incidence of CHF and unstable angina in patients with score [less than or equal to] 4. A Kaplan-Meier curve was plotted for duration of mechanical ventilation for these three groups (Fig 2). Patients with lower scores were associated with shorter duration of mechanical ventilation, and were more likely to be successfully extubated at 10 h (Table 5).

[FIGURE 2 OMITTED]

Receiver Operating Curve

The receiver operating curve (ROC) was plotted for different thresholds of the SSS and PMV > 48 h as the end point (Fig 3). In addition to the threshold of zero used in the original description, we used thresholds of -1.95, 0.71, 0.6, 0.69, and 1.95, which correspond to the 10th, 25th, 50th, 75th, and 90th percentiles of the SSS. Patients with a score > 0 and threshold of 0.6 had the optimal combination of sensitivity and false-positive rate (1 - specificity). The sensitivity and false-positive rate for patients with a score > 0 and threshold of 0.6 were 80%, 81%, 51%, and 48%, respectively.

[FIGURE 3 OMITTED]

Linear Regression Model

A simple linear regression model was also used to assess the association of each scoring system and the duration of mechanical ventilation (Table 6). The association between the SSS and the duration of mechanical ventilation was linear ([beta] = 0.06; 95% confidence interval [CI], 0.02 to 0.1). However, "lack of fit" was significant for the SSS linear regression model (p = 0.003). Further attempts to assess a quadratic, cubic, or quartic relationship between the two variables were unsuccessful. The association between the CRS and the duration of mechanical ventilation was also linear ([beta] = 0.05; 95% CI, 0.02 to 0.07), and lack of fit was NS. The Pearson product correlation coefficients were low for both the scoring systems (r = 0.15 and r = 0.21 for SSS and CRS, respectively).

Length of Stay and Mortality

The duration of ICU and hospital stay and 30-day mortality for the different subgroups of SSS and CRS are summarized in Tables 2, 5. Both the SSS and the CRS were predictors of length of ICU stay, while the CRS did predict 30-day mortality. However, neither scoring system predicted the length of hospital stay.

DISCUSSION

Our study validates efficacy of both previously proposed scoring systems. The PPV and NPV of a diagnostic test are influenced by the prevalence of the condition. Although PMV is a common complication after CABG, the incidence is low (5.2% at 48 h). Therefore, despite good sensitivity and specificity, a diagnostic test will have a low PPV and a high NPV. Most patients will be successfully extubated after CABG. The SSS was able to identify approximately half of these patients preoperatively. Only 3 of the 18 patients who could not be successfully extubated at 48 h had SSS [less than or equal to] 0 (NPV of 98%). However, only 8.5% of patients with SSS > 0 had PMV > 48 h. Therefore, the SSS can be used as a screening tool to identify low-risk patients who may proceed to surgery without further evaluation. However, the poor PPVs among patients with SSS > 0 suggests that further risk stratification is necessary for this group.

At first glance, the SSS may appear complicated for routine use. However, careful attention to the formula to calculate the SSS may simplify its clinical application. Patients with none or a single COMFAC risk factor will always have a SSS > 0, whereas those with more than one risk factor always had SSS > 0. This will occur irrespective of EF. Therefore, determining the presence or absence of history of diabetes, unstable angina, smoking, and CHF prior to hospital admission would be adequate to risk stratify these patients. Figure 4 shows a simplified approach to the SSS.

[FIGURE 4 OMITTED]

Although the SSS and CRS have similar efficacy to predict risk of PMV, they have important differences. The CRS emphasizes both preoperative and immediate postoperative variables to predict early extubation (< 10 h), whereas the SSS is based on preoperative risk factors alone to predict PMV at 48 h. In the SSS, comorbid risk factors are the most important determinants, whereas demographic characteristics like age and gender are not included. In contrast, the CRS emphasizes postoperative variables, such as excessive bleeding or intra-aortic balloon pump placement. Also, different definitions of PMV were used to calculate these scoring systems.

The ROC compares sensitivity and the false-positive rate for various thresholds of the SSS. The thresholds of 0.6 and 0 are associated with the best combination of sensitivity and false-positive rate. Using a lower threshold would increase the false-positive rate dramatically with minimal improvement in sensitivity. However, using a higher threshold would reduce the sensitivity with minimal reduction in the false-positive rate. The threshold of 0.6 has similar sensitivity but slightly lower false-positive rate (48% vs 51%, respectively) compared to the threshold of zero. However, it is not necessary to calculate the actual score to use the zero threshold. Therefore, the SSS > 0 offers the best combination of sensitivity, false-positive rate, and ease of use at the bedside.

A simple linear regression model to determine association between individual scoring systems and duration of mechanical ventilation demonstrated poor correlation coefficients for both scores. This finding suggests that both scoring systems describe only a small portion of the total variability in duration of mechanical ventilation.

Additional information, such as pulmonary function test (PFT) results, may improve the SSS. However, the role of PFTs in predicting PMV after CABG remains controversial. (2,3,7-9) Spivack et al (5) originally suggested different formulas for patients undergoing elective and urgent CABG. PFT results (FE[V.sub.1]/FVC < 50%) and preoperative PC[O.sub.2] appeared to have a small effect on the ability to predict PMV only in the subgroups of patients undergoing urgent CABG. PFTs and arterial blood gas analysis are not routinely performed in all patients at our institution, and therefore were not available in our study. We therefore used the same scoring system in all patients. However, our PPV and NPV were similar to the original study (10% and 97% for elective group and 22% and 96% for urgent group, respectively). Patients undergoing emergent or salvage CABG were excluded in the study by Spivack et al. (5) The lack of efficacy in patients undergoing emergent and salvage CABG in our study may be a type II statistical error due to fewer patients in this subgroup. In addition, preoperative spirometry is seldom performed in this subgroup, as the benefit of surgery outweighs the risk of postoperative complications.

To conclude, the SSS can be used as a preoperative screening tool to risk-stratify patients undergoing elective and urgent CABG. The SSS is simple and can be calculated based on a four point questionnaire: does the patient have history of unstable angina, diabetes, smoking, and CHF prior to hospital admission? Patients with SSS [less than or equal to] 0 are at low risk for PMV and can proceed to surgery without further evaluation. Patients with SSS > 0 are at higher risk for PMV and may require further risk stratification.

REFERENCES

(1) American Heart Association. Available at: http.//www.americanheart.org. Accessed June 13, 2002

(2) STS National Database. Available at: http.//www.ctsnet.org. Accessed June 13, 2002

(3) Zibrak JD, Marton K. Preoperative pulmonary function testing: position paper. Ann Intern Med 1990; 112:793-794

(4) Zibrak JD, O'Donnell CR, Marton K. Indications for pulmonary function testing. Ann Intern Med 1990; 112:763-771

(5) Spivack SD, Shinozaki T, Albertini JJ, et al. Preoperative prediction of postoperative respiratory outcome: coronary artery bypass grafting. Chest 1996; 109:1222-1230

(6) Wong DT, Cheng DC, Kustra R, et al. Risk factors of delayed extubation, prolonged length of stay in the intensive care unit and mortality in patients undergoing coronary artery bypass graft surgery with fast track cardiac anesthesia. Anesthesiology 1999; 91:936-944

(7) Jacob B, Amoateng-Adjepong Y, Rasakulasuriar S, et al. Preoperative pulmonary function tests do not predict outcome after coronary artery bypass. Conn Med 1997; 61:327-332

(8) Cain HD, Stevens PM, Adaniya R. Preoperative pulmonary function and complications after cardiovascular surgery. Chest 1979; 76:130-135

(9) Ferguson MK. Preoperative assessment of pulmonary risk. Chest 1999; 115:58S-63S

* From the Physician Research Network, Methodist Healthcare University Hospital, Memphis, TN.

This study was funded by Methodist Lebonheur Healthcare Foundation.

Manuscript received March 5, 2001; revision accepted January 16, 2002.

Correspondence to: Sachin Yende, MD, 501 Crews Wing, 1265 Union Ave, Memphis, TN 38104; e-mail: yende@juno.com

COPYRIGHT 2002 American College of Chest Physicians
COPYRIGHT 2002 Gale Group

Return to Levophed
Home Contact Resources Exchange Links ebay